Clonal haematopoiesis of indeterminate potential in cardiovascular medicine: is it time for selective testing?
Clicks: 4
ID: 321402
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #310 of 330 articles by views in european heart journal
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 330 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Clonal haematopoiesis of indeterminate potential (CHIP), a recently recognized, age-related cardiovascular risk factor, results from acquired, somatic mutations in a subset of known leukaemia driver genes in haematopoietic stem or progenitor cells. While prior work suggested that screening for these somatic mutations, which requires DNA sequencing, was premature due to lack of actionable evidence-based interventions, this review proposes that in light of the rapidly accumulating knowledge regarding CHIP, selective clinical testing by cardiovascular clinicians is now justified for specific high-risk individuals to improve cardiovascular risk stratification and inform preventive care. By identifying distinct mutations and estimating their burden (variant allele fraction), clinicians can understand better an individual's CHIP-related cardiovascular risk and tailor surveillance and management strategies, even before validation of targeted therapies. This review advocates a biologically driven approach to selective assessment of CHIP that leverages the advances in understanding this condition and its clinical consequences.
| Reference Key |
openalex_W7169585749
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ohad Oren, Peter Libby |
| Journal | european heart journal |
| Year | 2026 |
| DOI |
10.1093/eurheartj/ehag454
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.